MISSION Therapeutics
Develops drugs for cancer treatments
Total raised
€51M
€51,382,270
Funding rounds
5
Investors
7
distinct backers
Active since
2013-10
latest 2025-10
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood37
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood22
base rate 12% (2+ rounds)
- ▲ 5 rounds raised
- ▲ €30M+ raised
- ▲ 11y since founding
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
5 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-10-17 | Other | €11M | IP Group,Pfizer Venture Investments,Roche Venture Fund,Rosetta Capital,Sofinnova Partners,SR One | View deal → |
| 2021-10-14 | Grant | €500k | Michael J Fox Foundation for Parkinson’s Research (MJFF) | View deal → |
| 2020-07-06 | Other | €13M | Pfizer Venture Investments | View deal → |
| 2015-09-01 | Grant | €2.3M | — | View deal → |
| 2013-11-01 | Series B | €24M | Roche Venture Fund,Sofinnova Partners | View deal → |